TGA
Fines for RATs
TGA fines manufacturer for multiple regulatory infringements The Therapeutic Goods Administration (TGA) has issued eight infringement notices totalling $106,560 to a manufacturers, Hough Pharma, for allegedly failing to provide information …
Fake RATs being sold
Some consumers may be using RATs not approved in Australia, which may not work as expected The TGA has issued a warning to the general public, urging people to only …
Docs slam S3 budesonide proposal
A proposal to downschedule budesonide would be harmful to patients as “pharmacists are not clinically trained to diagnose and treat asthma,” says the RACGP And difficulty accessing GPs in rural …
Fines galore
The TGA has issued a slew of infringement notices, including a series totalling more than $133,000 to one entity The TGA issued ten infringement notices totalling $133,200 to Philips Electronics …
The week in review
A new Government and warnings of a terrible flu season… it’s been an interesting week Over the weekend, Australia ousted the Morrison Coalition Government and voted in Labor, led by …
Changes to the schedule
Mouth ulcer treatment and flurbiprofen to be downscheduled, TGA announces The Therapeutic Goods Administration has confirmed that the mouth ulcer treatment choline salicylate is to be downscheduled to Schedule 2 …
TGA cancels FatBlaster Max listing
The product’s weight loss claims allegedly breached legislation, though its sponsor will appeal the decision The TGA has cancelled the listed complementary medicine FatBlaster Max (AUST L 348163) from the …
Blackroot salesman sentenced
Queensland company FuturePro and its director convicted for selling unregistered products A former air-conditioning electrician and company Future Pro have both been convicted of a number of charges around the …
Mould growth prompts TGA alert
A Swisse collagen product has been urgently recalled, the TGA says The TGA has announced an urgent nationwide recall of Swisse’s Beauty Collagen Glow Gummies because of the discovery of mould …
TGA to investigate ‘intentional’ paracetamol misuse
Report commissioned to look at self-harm risks from paracetamol The TGA has announced a report on the risks of self-harm from intentional paracetamol misuse. It commissioned the report, to be produced …
Supply ‘constrained’ but improving
Substitution instrument extended for abatacept, while others end The Serious Scarcity Substitution Instrument (SSSI) for abatacept (Orencia), originally set to expire on 30 April, has been extended until 30 June. …
The week in review
New standards, TGA announcements and a CPI rise all made the headlines this week The TGA recalled several sunscreen products from different brands, concerned about benzene contamination… it’s been a …